1.98
1.98 (0%)
As of Apr 17, 2025
Bluejay Diagnostics, Inc. [BJDX]
Source:
Company Overview
Bluejay Diagnostics, Inc. is a medical diagnostics company developing rapid tests using whole blood on our Symphony technology platform to improve patient outcomes in critical care settings.
| Country | United States |
| Headquarters | acton, massachusetts |
| Phone Number | (844) 327-7078 |
| Industry | manufacturing |
| CEO | Neil Dey |
| Website | www.bluejaydx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-1.4 |
| Net Income | $-1.5 |
| Net Cash | $3.5 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -22.4% |
| Profit as % of Stockholder Equity | -20.7% |
Management Effectiveness
| Return on Equity | -20.7% |
| Return on Assets | -17.7% |
| Turnover Ratio | |
| EBITA | $-1.4 |
Balance Sheet and Cash Flow Measures
| Total Assets | $8.4 |
| Total Liabilities | $1.2 |
| Operating Cash Flow | $-6.1 |
| Investing Cash Flow | $-0.3 |
| Financing Cash Flow | $9.9 |
